ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

THOMAS HARBURG M.D.

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,030Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 25

$440K Total Retail Price of All Prescriptions

Rank: 6 out of 25

505 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 16%.

Schedule Three
Controlled Substances

16% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,544 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 442 379 1 4
LISINOPRIL 381 340 2 3
HYDROCODONE-ACETAMINOPHEN 367 273 S3 3 7
ATENOLOL 307 296 4 11
OMEPRAZOLE 282 227 5 1
HYDROCHLOROTHIAZIDE 215 197 6 14
FUROSEMIDE 198 181 7 5
METOPROLOL TARTRATE 193 173 8 9
OXYCODONE HCL 187 71 S2 9 23
METFORMIN HCL 183 165 10 13
TRAZODONE HCL 174 148 11 18
WARFARIN SODIUM 160 147 12 8
K-TAB 159 143 13 56
LEVOTHROID 157 147 14 42
PROAIR HFA 151 112 15 36
MORPHINE SULFATE ER 146 74 S2 16 44
ALENDRONATE SODIUM 142 136 17 20
LOSARTAN POTASSIUM 135 127 18 15
AMLODIPINE BESYLATE 132 119 19 6
GLIPIZIDE 121 106 20 35
FAMOTIDINE 116 92 21 62
CITALOPRAM HBR 105 93 22 10
OXYCODONE-ACETAMINOPHEN 94 58 S2 23 47
LEVOTHYROXINE SODIUM 93 85 24 2
FLUTICASONE PROPIONATE 80 65 25 50
GABAPENTIN 75 58 26 17
QVAR 68 48 27 132
FLUOXETINE HCL 67 42 28 37
TAMSULOSIN HCL 67 49 28 28
METOPROLOL SUCCINATE 65 57 30 16
PRAVASTATIN SODIUM 63 42 31 26
SERTRALINE HCL 62 61 32 24
MORPHINE SULFATE 56 18 S2 33 82
METHOCARBAMOL 56 38 R 33 144
IBUPROFEN 55 34 35 90
ACETAMINOPHEN-CODEINE 55 50 S3 35 103
FINASTERIDE 54 40 37 145
CLOPIDOGREL 53 52 38 52
PAROXETINE HCL 52 46 39 55
ALLOPURINOL 52 38 39 31
DILT-XR 51 51 41 154
ATORVASTATIN CALCIUM 50 41 42 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.